1. Academic Validation
  2. A tale of two proteins: PACT and PKR and their roles in inflammation

A tale of two proteins: PACT and PKR and their roles in inflammation

  • FEBS J. 2021 Nov;288(22):6365-6391. doi: 10.1111/febs.15691.
Evelyn Chukwurah 1 Kenneth T Farabaugh 2 Bo-Jhih Guan 1 Parameswaran Ramakrishnan 3 Maria Hatzoglou 1
Affiliations

Affiliations

  • 1 Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • 2 Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA.
  • 3 Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Abstract

Inflammation is a pathological hallmark associated with Bacterial and viral infections, autoimmune diseases, genetic disorders, obesity and diabetes, as well as environmental stresses including physical and chemical trauma. Among numerous proteins regulating proinflammatory signaling, very few such as Protein kinase R (PKR), have been shown to play an all-pervading role in inflammation induced by varied stimuli. PKR was initially characterized as an interferon-inducible gene activated by viral double-stranded RNA with a role in protein translation inhibition. However, it has become increasingly clear that PKR is involved in multiple pathways that promote inflammation in response to stress activation, both dependent on and independent of its cellular protein activator of PKR (PACT). In this review, we discuss the signaling pathways that contribute to the initiation of inflammation, including Toll-like Receptor, interferon, and RIG-I-like Receptor signaling, as well as inflammasome activation. We go on to discuss the specific roles that PKR and PACT play in such proinflammatory signaling, as well as in metabolic syndrome- and environmental stress-induced inflammation.

Keywords

PACT; PKR; RIG-I-like receptors; inflammasome; inflammation; metaflammation.

Figures
Products